Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 333 followers
Latest posts
Last updated about 14 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Quviviq, Daridorexant, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: EMA/PE/0000233864
about 15 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Quviviq, Daridorexant, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Voxzogo, vosoritide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000224087
about 15 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Voxzogo, vosoritide, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Jyseleca, filgotinib maleate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: EMA/P
about 15 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Jyseleca, filgotinib maleate, decision type...
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 12, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation...
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of authorisation: 09/01/2026, Revision: 2, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Ondibta, insulin glargine, Date of...
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 6, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Date of authorisation: 10/02/2026, Revision: 1, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zypadhera, olanzapine, Date of authorisation: 19/11/2008, Revision: 27, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Zypadhera, olanzapine, Date of authorisation...
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 18, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation...
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation: 26/07/2023, Revision: 7, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Ztalmy, ganaxolone, Date of authorisation...